Nivolumab vs Sumatriptan

## Nivolumab vs Sumatriptan: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Sumatriptan**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Sumatriptan**: Selective 5-HT1B/1D receptor agonist.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Sumatriptan — 2.5 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Sumatriptan — C14H21N3O2S.

**Molecular Weight**: Nivolumab — N/A; Sumatriptan — 295.4020 g/mol.

**Type**: Nivolumab — Antibody; Sumatriptan — Small molecule.